A Single- and Multiple-Dose Study of Enlicitide Chloride (MK-0616) in Healthy Chinese Adult Participants (MK 0616-010)
Clinical trial NCT06814106 · COMPLETED
Trial details
- NCT number
- NCT06814106
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-06
- Primary completion
- 2023-05-08
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.